论文部分内容阅读
研究目的是判定可溶性Ｌ选择素(ｓＬｓｅｌｅｃｔｉｎ)是否为糖尿病伴发冠状动脉疾病(ＣＡＤ)的可靠标志以及是否有助于在2型糖尿病患者中筛检无症状性心肌缺血(ＳＭＩ)。病人与方法 研究对象包括45例不伴急性或慢性炎性疾病的2型糖尿病患者及22例健康志愿者。分组如下:1组,包
The aim of the study was to determine whether soluble L-selectin is a reliable marker of diabetic patients with coronary artery disease (CAD) and whether it helps screen for asymptomatic myocardial ischemia (SMI) in patients with type 2 diabetes. Patients and Methods Subjects included 45 patients with type 2 diabetes without acute or chronic inflammatory disease and 22 healthy volunteers. Groups are as follows: 1 group, package